In line with these findings, endogenous galectin-3 was found to exacerbate inflammation in a mouse model for asthma [118], while the pharmacological administration of galectin-3 revealed a protective effect in bronchial obstruction [119]. The gene discussed is LGALS3; the disease is asthma.